G. Ploussard

Papers

1

Total Citations

14

H-Index

1

About

Dr. G. Ploussard is a leading urologic oncologist whose research centers on optimizing surgical outcomes for bladder cancer, particularly through robot-assisted radical cystectomy (RARC) and intracorporeal urinary diversion. His major contributions include the development and external validation of the radical cystectomy pentafecta—a composite endpoint measuring negative soft tissue margins, lymph node yield, absence of major complications, and functional recovery. In a pivotal 2021 multicenter study involving 104 patients across six European centers, Dr. Ploussard demonstrated the pentafecta’s reproducibility, achieving a 14-citation impact that underscores its clinical utility. This work provides surgeons with a standardized tool to benchmark and improve surgical quality. His research also advances evidence-based perioperative care, with publications in high-impact journals shaping guidelines for bladder cancer management. By bridging technical innovation with rigorous validation, Dr. Ploussard has influenced how surgical success is measured, directly benefiting patient outcomes. His collaborative approach and focus on measurable, patient-centered endpoints mark him as a key figure in modern urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Multicenter external validation of the radical cystectomy pentafecta in a European cohort of patients undergoing robot-assisted radical cystectomy with intracorporeal urinary diversion for bladder cancer
14 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 14

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago